The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...

The ongoing trade conflict and increasing economic concerns weigh heavily on earnings expectations. Yet, forecasts for the US ...

Philip Morris shares have risen by more than 50% in the past twelve months – the transformation is going well. In an ...

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

Following the recent near-financial crash, calls to exclude US government bonds from banks’ capital ratios are growing louder ...

After Accelleron, ABB is preparing its next billion dollar IPO. The new CEO is making his mark and delivers good results.

The US insurer Willis Towers Watson is an alternative to defensive US stocks from the food industry. The business is ...

Sensirion does not see itself affected by US tariff policy. New regulation is driving the sensor specialist’s business this ...

Six investment professionals tell our readers how to navigate in view of new US trade barriers. Today Philipp Lienhardt, Head ...

The violent market movements are a stress test for stocks rated as «immune to fluctuations». Some withstand the turbulences ...

In the USA and the UK, government bonds are coming under pressure and interest rates have risen. This is apparently due to ...

The shares of the private equity group collapse. But the strategic direction is right. What investors should do now.